Action on EB request on Polio Vaccination of Travellers

WHO takes steps to assess public health benefits of tightening application of polio vaccination recommendations for travellers

A Hajjah – female Islamic pilgrim – receives the polio vaccine at a Hajj Camp, as she begins the holy pilgrimage to Mecca. ©UNICEF Pakistan/Zaidi
A Hajjah – female Islamic pilgrim – receives the polio vaccine at a Hajj Camp, as she begins the holy pilgrimage to Mecca.
©UNICEF Pakistan/Zaidi

The World Health Organization (WHO) is taking immediate steps to assess the public health benefits of tightening the application of polio vaccination recommendations for travellers from polio-infected areas. These steps are being taken in response to a request by WHO Member States convening at the organization’s Executive Board (EB) in January 2014.

This request of Member States reflects growing concern about the substantial international spread of polio from key infected areas in 2013. Last year, poliovirus originating from polio-endemic countries resulted in major outbreaks in the Horn of Africa and the Middle East. Some WHO Member States, including the Kingdom of Saudi Arabia, already require that travellers from polio-affected areas show proof of vaccination before they are issued entry visas.

As an immediate first step, WHO convened the independent Polio Working Group of the Strategic Advisory Group of Experts on immunization (SAGE) on 5-6 February 2014 to review existing definitions for polio-infected areas, update WHO’s polio vaccination recommendations for travellers from infected areas based on new information and evidence, and identify potential operational and other considerations that would need to be evaluated in tightening the international application of such recommendations. These updated policy recommendations are summarized in the new ‘Polio vaccines: WHO position paper, January 2014’, published in the WHO Weekly Epidemiologic Record on 28 February 2014 and will be published in full in the 2014 edition of WHO’s International Travel and Health in April 2014.
The deliberations and recommendations of the SAGE Polio Working Group will be discussed by SAGE in April 2014 and inform deliberations under the International Health Regulations concerning potential measures for reducing the international spread of polioviruses.

Related

Polio vaccines: WHO position paper, January 2014
WHO International Travel and Health
GPEI report on polio eradication to the 134th Executive Board (January 2014) [pdf]
Strategic Advisory Group of Experts on immunization (SAGE)

Related


Related News

   14/09/2021
Update on polio eradication efforts in Pakistan for August 2021
   14/09/2021
GPEI joins the 5-year action journey to achieve irreversible progress towards gender equality
   27/08/2021
Three polio survivors from Mozambique, Congo and Ethiopia share their experiences of living with the effects of disease, and their hope for a polio-free world.
   27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
   27/08/2021
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.